Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-16-017713

President and CEO sold 135,788 shares at an average $27.20 ($3,693,795)

  • President and CEO acquired 135,788 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pomerantz Roger · President and CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2016-04-01 Exercise or conversion : show line 1 in the form +90,963 $0.48 $43,662 113,690 D
2016-04-01 Sale : show line 2 in the form −40,506 $25.69 $1,040,599 73,184 D
2016-04-01 Sale : show line 3 in the form −38,080 $26.67 $1,015,594 35,104 D
2016-04-01 Sale : show line 4 in the form −12,377 $27.56 $341,110 22,727 D
2016-04-04 Exercise or conversion : show line 5 in the form +44,825 $0.48 $21,516 67,552 D
2016-04-04 Sale : show line 6 in the form −15,203 $28.17 $428,269 52,349 D
2016-04-04 Sale : show line 7 in the form −22,418 $29.18 $654,157 29,931 D
2016-04-04 Sale : show line 8 in the form −6,416 $29.68 $190,427 23,515 D
2016-04-04 Sale : show line 9 in the form −788 $30.00 $23,640 22,727 D
Open-market sales · 135,788 sh · avg $27.20 · $3,693,795

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-04-01 Exercise or conversion : show line 10 in the form Stock Option (right to buy) −90,963 $0.48 2023-11-06 90,963 129,037 D
2016-04-04 Exercise or conversion : show line 11 in the form Stock Option (right to buy) −44,825 $0.48 2023-11-06 44,825 84,212 D
Loading xslF345X03/doc4.xml…